{"news_desk": "Editorial", "print_page": "22", "section_name": "Opinion", "subsection_name": null, "byline": {"original": "By THE EDITORIAL BOARD", "person": [], "organization": "THE EDITORIAL BOARD"}, "abstract": "Editorial calls on Senate to scrutinize Dr Robert Califf\u2019s ties to pharmaceutical industry for conflicts of interest before confirming him as head of Food and Drug Administration; cites respected cardiologist and researcher's history of payments as consultant to industry and his remarks in speech that regulations were 'barrier' to innovation. ", "type_of_material": "Editorial", "word_count": "408", "lead_paragraph": "The new commissioner, who has long-standing ties to the drug industry, must keep the agency from succumbing to industry demands.", "pub_date": "2015-11-16T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Questions for President Obama\u2019s Nominee to lead the F.D.A.", "content_kicker": "Editorial", "print_headline": "Questions for the F.D.A. Nominee", "kicker": "Editorial"}, "snippet": "The new commissioner, who has long-standing ties to the drug industry, must keep the agency from succumbing to industry demands.", "multimedia": [{"height": 126, "url": "images/2015/11/14/opinion/16mon3web/16mon3web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/14/opinion/16mon3web/16mon3web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/11/14/opinion/16mon3web/16mon3web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/11/14/opinion/16mon3web/16mon3web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/14/opinion/16mon3web/16mon3web-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/14/opinion/16mon3web/16mon3web-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/16/opinion/questions-for-president-obamas-nominee-to-lead-the-fda.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Editorials", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Califf, Robert M", "name": "persons"}, {"rank": "3", "is_major": "N", "value": "Regulation and Deregulation of Industry", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Project on Government Oversight", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Duke University Medical Center", "name": "organizations"}, {"rank": "7", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}], "blog": [], "_id": "564991c638f0d81963b74634", "source": "The New York Times"}